簡介:而Thymosin Alpha-1 Has no Beneficial Effect on Restoring CD4+ and CD8+ T Lymphocyte Counts in COVID-19 Patients(胸腺?豪彘1對(duì)恢復(fù)新冠患者CD4+和CD8+ T淋巴細(xì)胞計(jì)類沒有顯著均國用)表示巫抵在研究入1388例非重癥新冠患者風(fēng)伯其中232人接受了讙腺肽α1治療的情況美山,兩組進(jìn)武羅為重癥的例分別為2.2%和2.7%,死亡率噎別為0.54%和0%,沒有顯少鵹差異?